{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:55:49Z","timestamp":1790841349178,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The impact of obesity and sex on asthma outcomes and inflammation in the real-world setting is not completely understood. The aim of this study was to profile obesity and other comorbidities in a cohort of male and female adults with asthma; to understand the impact of obesity on asthma outcomes; and to examine sex-specific relationships between obesity and airway inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We profiled comorbidities including obesity, as well as clinical asthma outcomes and airway inflammation, in patients with asthma enrolled in the Australasian Severe Asthma Registry. Data were analysed using\n                      <jats:italic>t<\/jats:italic>\n                      -tests (parametric data) or Wilcoxon rank sum tests (non-parametric data). Analysis of covariance (ANCOVA) was used to examine the effects of obesity and asthma severity on clinical and inflammatory outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We assessed 1,019 patients with severe (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009882) and non-severe (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009137) asthma. Patients with severe asthma were 67% more likely to have obesity, while patients with severe asthma and obesity were more likely to be female. Obesity was associated with a higher prevalence of asthma-related hospitalisation in the previous 12 months, in both severe (26.2% vs. 15.7%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and non-severe asthma (12.5% vs. 3.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Obesity was also associated with poorer asthma control and lung function, and higher sputum neutrophils. Interestingly, sputum %neutrophils correlated with body mass index in females (\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>s<\/jats:italic>\n                      <\/jats:sub>\n                      =0.370,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003), but not males (\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sub>\n                        <jats:italic>s<\/jats:italic>\n                      <\/jats:sub>\n                      =0.092,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.495). Neutrophilic airway inflammation was associated with poorer lung function and asthma control.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates that obesity is associated with a significantly worse clinical asthma presentation in the real-world setting and increases the risk of asthma-related hospitalisation. Critically, our findings suggest that obesity is associated with increased neutrophilic airway inflammation in females, but not males, providing some insight into possible sex-related differences in severe asthma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-026-03872-3","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T02:06:12Z","timestamp":1787277972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between asthma, obesity and other comorbidities: the Australasian Severe Asthma Registry"],"prefix":"10.1186","volume":"27","author":[{"given":"Hayley A","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"3872_CR1","unstructured":"ABS. Asthma Latest release Contains key statistics and information about asthma and its prevalence in Australia 2022. Available from: https:\/\/www.abs.gov.au\/statistics\/health\/health-conditions-and-risks\/asthma\/latest-release."},{"issue":"2","key":"3872_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343\u201373.","journal-title":"Eur Respir J"},{"key":"3872_CR3","doi-asserted-by":"crossref","unstructured":"Foster JM, McDonald VM, Guo M, Reddel HK. I have lost in every facet of my life: the hidden burden of severe asthma. Eur Respir J. 2017;50(3).","DOI":"10.1183\/13993003.00765-2017"},{"key":"3872_CR4","unstructured":"GINA. Global Strategy for Asthma Management and Prevention 2025 Available from. https:\/\/www.ginasthma.org."},{"issue":"6","key":"3872_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/cea.13153","volume":"48","author":"SA Hiles","year":"2018","unstructured":"Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, et al. Working while unwell: Workplace impairment in people with severe asthma. Clin experimental allergy: J Br Soc Allergy Clin Immunol. 2018;48(6):650\u201362.","journal-title":"Clin experimental allergy: J Br Soc Allergy Clin Immunol"},{"issue":"2","key":"3872_CR6","first-page":"74","volume":"17","author":"M Sadatsafavi","year":"2010","unstructured":"Sadatsafavi M, Lynd L, Marra C, Carleton B, Tan WC, Sullivan S, et al. Direct health care costs associated with asthma in British Columbia. Can Respir J. 2010;17(2):74\u201380.","journal-title":"Can Respir J"},{"issue":"10431","key":"3872_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NH Phelps","year":"2024","unstructured":"Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027\u201350.","journal-title":"Lancet"},{"issue":"7","key":"3872_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1164\/rccm.200611-1717OC","volume":"175","author":"DA Beuther","year":"2007","unstructured":"Beuther DA, Sutherland ER. Overweight, Obesity, and Incident Asthma. Am J Respir Crit Care Med. 2007;175(7):661\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"3872_CR9","doi-asserted-by":"publisher","first-page":"m234","DOI":"10.1136\/bmj.m234","volume":"368","author":"X Li","year":"2020","unstructured":"Li X, Cao X, Guo M, Xie M, Liu X. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017. BMJ. 2020;368:m234.","journal-title":"BMJ"},{"issue":"6","key":"3872_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1164\/rccm.201208-1470OC","volume":"188","author":"D Desai","year":"2013","unstructured":"Desai D, Newby C, Symon FA, Haldar P, Shah S, Gupta S, et al. Elevated Sputum Interleukin-5 and Submucosal Eosinophilia in Obese Individuals with Severe Asthma. Am J Respir Crit Care Med. 2013;188(6):657\u201363.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3872_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1183\/09031936.00139810","volume":"38","author":"HA Scott","year":"2011","unstructured":"Scott HA, Gibson PG, Garg ML, Wood LG. Airway inflammation is augmented by obesity and fatty acids in asthma. Eur Respir J. 2011;38(3):594.","journal-title":"Eur Respir J"},{"issue":"12","key":"3872_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11882-021-01024-9","volume":"21","author":"V Sharma","year":"2021","unstructured":"Sharma V, Cowan DC. Obesity, Inflammation, and Severe Asthma: an Update. Curr Allergy Asthma Rep. 2021;21(12):46.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"3872_CR13","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","volume":"141","author":"U Peters","year":"2018","unstructured":"Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol. 2018;141(4):1169\u201379.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3872_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/all.14548","volume":"76","author":"CA Alemao","year":"2020","unstructured":"Alemao CA, Budden KF, Gomez HM, Rehman SF, Marshall JE, Shukla SD, et al. Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders. Allergy. 2020;76(3):714\u201334.","journal-title":"Allergy"},{"issue":"2","key":"3872_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"3872_CR16","unstructured":"GINA. Diagnosis and Management of Difficult-to-treat and Severe Asthma in adolescent and adult patients 2019. April 2019: Available from: https:\/\/ginasthma.org\/severeasthma\/."},{"issue":"2","key":"3872_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/thx.47.2.76","volume":"47","author":"EF Juniper","year":"1992","unstructured":"Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47(2):76\u201383.","journal-title":"Thorax"},{"issue":"1","key":"3872_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","volume":"113","author":"RA Nathan","year":"2004","unstructured":"Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, et al. Development of the asthma control test\u2606A survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59\u201365.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"3872_CR19","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","volume":"14","author":"EF Juniper","year":"1999","unstructured":"Juniper EF, O\u2032byrne PM, Gh G, Pj F. King Dr. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902.","journal-title":"Eur Respir J"},{"issue":"10095","key":"3872_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","volume":"390","author":"PG Gibson","year":"2017","unstructured":"Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet. 2017;390(10095):659\u201368.","journal-title":"Lancet"},{"issue":"1","key":"3872_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1164\/ajrccm.158.1.9705031","volume":"158","author":"PG Gibson","year":"1998","unstructured":"Gibson PG, Wlodarczyk JW, Hensley MJ, Gleeson M, Henry RL, Cripps AW, et al. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood. Am J Respir Crit Care Med. 1998;158(1):36\u201341.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3872_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/resp.12079","volume":"18","author":"CR Brooks","year":"2013","unstructured":"Brooks CR, Gibson PG, Douwes J, Van Dalen CJ, Simpson JL. Relationship between airway neutrophilia and ageing in asthmatics and non-asthmatics. Respirol (Carlton Vic). 2013;18(5):857\u201365.","journal-title":"Respirol (Carlton Vic)"},{"issue":"5","key":"3872_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1513\/pats.200903-013ST","volume":"7","author":"AE Dixon","year":"2010","unstructured":"Dixon AE, Holguin F, Sood A, Salome CM, Pratley RE, Beuther DA, et al. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc. 2010;7(5):325\u201335.","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"3872_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1378\/chest.12-0872","volume":"143","author":"D Gibeon","year":"2013","unstructured":"Gibeon D, Batuwita K, Osmond M, Heaney LG, Brightling CE, Niven R, et al. Obesity-Associated Severe Asthma Represents a Distinct Clinical Phenotype Analysis of the British Thoracic Society Difficult Asthma Registry Patient Cohort According to BMI. Chest. 2013;143(2):406\u201314.","journal-title":"Chest"},{"issue":"4","key":"3872_CR25","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","volume":"157","author":"E Wang","year":"2020","unstructured":"Wang E, Wechsler ME, Tran TN, Heaney LG, Jones RC, Menzies-Gow AN, et al. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry. Chest. 2020;157(4):790\u2013804.","journal-title":"Chest"},{"key":"3872_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","volume":"960","author":"A Engin","year":"2017","unstructured":"Engin A. The Definition and Prevalence of Obesity and Metabolic Syndrome. Adv Exp Med Biol. 2017;960:1\u201317.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3872_CR27","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4132\/jptm.2022.11.14","volume":"57","author":"A Ray","year":"2023","unstructured":"Ray A, Bonorden MJL, Pandit R, Nkhata KJ, Bishayee A. Infections and immunity: associations with obesity and related metabolic disorders. J Pathol translational Med. 2023;57(1):28\u201342.","journal-title":"J Pathol translational Med"},{"issue":"3","key":"3872_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218\u201324.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3872_CR29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.jaci.2013.10.011","volume":"133","author":"WC Moore","year":"2014","unstructured":"Moore WC, Hastie AT, Li X, Li H, Busse WW, Jarjour NN, et al. Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol. 2014;133(6):1557\u2013e635.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"3872_CR30","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jaip.2017.01.027","volume":"5","author":"P Ilmarinen","year":"2017","unstructured":"Ilmarinen P, Tuomisto LE, Niemel\u00e4 O, Tommola M, Haanp\u00e4\u00e4 J, Kankaanranta H. Cluster Analysis on Longitudinal Data of Patients with Adult-Onset Asthma. J Allergy Clin Immunology: Pract. 2017;5(4):967\u2013e783.","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"3","key":"3872_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jaci.2015.01.013","volume":"136","author":"J Fingleton","year":"2015","unstructured":"Fingleton J, Travers J, Williams M, Charles T, Bowles D, Strik R, et al. Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. J Allergy Clin Immunol. 2015;136(3):601\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3872_CR32","doi-asserted-by":"publisher","first-page":"e36631","DOI":"10.1371\/journal.pone.0036631","volume":"7","author":"ER Sutherland","year":"2012","unstructured":"Sutherland ER, Goleva E, King TS, Lehman E, Stevens AD, Jackson LP, et al. Cluster Analysis of Obesity and Asthma Phenotypes. PLoS ONE. 2012;7(5):e36631.","journal-title":"PLoS ONE"},{"issue":"10","key":"3872_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/thorax-2022-219268","volume":"78","author":"HA Scott","year":"2023","unstructured":"Scott HA, Ng SH, McLoughlin RF, Valkenborghs SR, Nair P, Brown AC, et al. Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis. Thorax. 2023;78(10):957\u201365.","journal-title":"Thorax"},{"key":"3872_CR34","first-page":"2949","volume-title":"Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk","author":"P Singh","year":"2021","unstructured":"Singh P, Covassin N, Marlatt K, Gadde KM, Heymsfield SB. Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk. Comprehensive Physiology: Wiley; 2021. pp. 2949\u201393."},{"key":"3872_CR35","doi-asserted-by":"crossref","unstructured":"Chang E, Varghese M, Singer K. Gender and Sex Differences in Adipose Tissue. Curr Diab Rep. 2018;18(9):69.","DOI":"10.1007\/s11892-018-1031-3"},{"key":"3872_CR36","unstructured":"Australian Bureau of Statistics. Causes of Death, Australia, 2024 \u2013 Latest release. 14 November 2025. Available from: https:\/\/www.abs.gov.au\/statistics\/health\/causes-death\/causes-death-australia\/latest-release."},{"issue":"16","key":"3872_CR37","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/archinte.1996.00440150091010","volume":"156","author":"EM Skobeloff","year":"1996","unstructured":"Skobeloff EM. The Effect of the Menstrual Cycle on Asthma Presentations in the Emergency Department. Arch Intern Med. 1996;156(16):1837.","journal-title":"Arch Intern Med"},{"issue":"4","key":"3872_CR38","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jaci.2017.11.034","volume":"141","author":"N McCleary","year":"2018","unstructured":"McCleary N, Nwaru BI, Nurmatov UB, Critchley H, Sheikh A. Endogenous and exogenous sex steroid hormones in asthma and allergy in females: A\u00a0systematic review and meta-analysis. J Allergy Clin Immunol. 2018;141(4):1510\u2013e38.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3872_CR39","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jaci.2011.01.036","volume":"127","author":"LG Wood","year":"2011","unstructured":"Wood LG, Garg ML, Gibson PG. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol. 2011;127(5):1133\u201340.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3872_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jaci.2018.04.037","volume":"143","author":"LG Wood","year":"2019","unstructured":"Wood LG, Li Q, Scott HA, Rutting S, Berthon BS, Gibson PG, et al. Saturated fatty acids, obesity, and the nucleotide oligomerization domain\u2013like receptor protein 3 (NLRP3) inflammasome in asthmatic patients. J Allergy Clin Immunol. 2019;143(1):305\u201315.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3872_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.37349\/eaa.2023.00010","volume":"1","author":"J Pepys","year":"2023","unstructured":"Pepys J, Lombardi C, Comberiati P, Landi M, Berti A, Heffler E, et al. Small airway dysfunction and obesity in asthmatic patients: a dangerous liaison? Explor Asthma Allergy. 2023;1(3):73\u201388.","journal-title":"Explor Asthma Allergy"},{"issue":"4","key":"3872_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1053\/rmed.2001.1035","volume":"95","author":"W Ladosky","year":"2001","unstructured":"Ladosky W, Botelho MAM, Albuquerque JP. Chest mechanics in morbidly obese non-hypoventilated patients. Respir Med. 2001;95(4):281\u20136.","journal-title":"Respir Med"},{"issue":"3","key":"3872_CR43","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1378\/chest.130.3.827","volume":"130","author":"RL Jones","year":"2006","unstructured":"Jones RL, Nzekwu M-MU. The Effects of Body Mass Index on Lung Volumes. Chest. 2006;130(3):827\u201333.","journal-title":"Chest"},{"issue":"9","key":"3872_CR44","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/17476348.2018.1506331","volume":"12","author":"AE Dixon","year":"2018","unstructured":"Dixon AE, Peters U. The effect of obesity on lung function. Expert Rev Respir Med. 2018;12(9):755\u201367.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"3872_CR45","doi-asserted-by":"publisher","first-page":"e000932","DOI":"10.1136\/bmjresp-2021-000932","volume":"8","author":"G Klepaker","year":"2021","unstructured":"Klepaker G, Henneberger PK, Hertel JK, Holla \u00d8L, Kongerud J, Fell AKM. Influence of asthma and obesity on respiratory symptoms, work ability and lung function: findings from a cross-sectional Norwegian population study. BMJ Open Respiratory Res. 2021;8(1):e000932.","journal-title":"BMJ Open Respiratory Res"},{"issue":"2","key":"3872_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1152\/japplphysiol.00329.2007","volume":"104","author":"RL Sorkness","year":"2008","unstructured":"Sorkness RL, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Chung KF, et al. Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol. 2008;104(2):394\u2013403.","journal-title":"J Appl Physiol"},{"issue":"6","key":"3872_CR47","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1213\/ANE.0000000000001885","volume":"125","author":"N Hoftman","year":"2017","unstructured":"Hoftman N, Eikermann E, Shin J, Buckley J, Navab K, Abtin F, et al. Utilizing Forced Vital Capacity to Predict Low Lung Compliance and Select Intraoperative Tidal Volume During Thoracic Surgery. Anesth Analgesia. 2017;125(6):1922\u201330.","journal-title":"Anesth Analgesia"},{"key":"3872_CR48","doi-asserted-by":"crossref","unstructured":"Nanzer AM, Taylor V, Hearn AP, Kavanagh JE, Patrick T, Green L, et al. The impact of steroid-sparing biologic therapies on weight loss in obese individuals with severe eosinophilic asthma. Eur Respir J. 2023;62(2):2300245.","DOI":"10.1183\/13993003.00245-2023"},{"key":"3872_CR49","doi-asserted-by":"crossref","unstructured":"Albers FC, Papi A, Taill\u00e9 C, Bratton DJ, Bradford ES, Yancey SW, et al. Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight\/body mass index: meta-analysis of MENSA and MUSCA. Respir Res. 2019;20(1):169.","DOI":"10.1186\/s12931-019-1134-7"},{"issue":"11","key":"3872_CR50","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1016\/j.jaip.2025.07.041","volume":"13","author":"S Gonem","year":"2025","unstructured":"Gonem S, Redmond C, Busby J, Patel P, Jackson DJ, Mansur AH, et al. Effects of Obesity on Response to Asthma Biologic Treatment: Longitudinal Data From the United Kingdom Severe Asthma Registry. J Allergy Clin Immunology: Pract. 2025;13(11):3002\u201310.","journal-title":"J Allergy Clin Immunology: Pract"},{"issue":"1","key":"3872_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pulmoe.2018.01.005","volume":"25","author":"MJ Oliveira","year":"2019","unstructured":"Oliveira MJ, Vieira M, Coutinho D, Ladeira I, Pascoal I, Ferreira J, et al. Severe asthma in obese patients: Improvement of lung function after treatment with omalizumab. Pulmonology. 2019;25(1):15\u201320.","journal-title":"Pulmonology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03872-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03872-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:02:56Z","timestamp":1790838176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03872-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3872"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03872-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prior to 2019, all patients provided written, informed consent. To ensure a representative population, a transition to opt-out consent was approved by the Australian Commission for Safety and Quality in Health Care in 2019. ASAR is under the governance of the Thoracic Society of Australia and New Zealand (TSANZ). Recruitment commenced in 2013, with systematic, de-identified, annual data collection via an electronic data capture system (REDCap) [\n                      \n                      ]. Ethical approval was obtained according to each site\u2019s Human Research Ethics Committee in Australia (2019\/ETH03836) and New Zealand (2\/CEN\/69\/AM09).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Unrelated to this study, Joy Lee has received speaker fees from Sanofi, GSK, Inside Practice, United Clinical, National Asthma Council and AstraZeneca. She has received travel grants from GSK, Sanofi and AstraZeneca. She is on the leadership committee of the National Allergy Centre of Excellence and has served on an advisory board for AstraZeneca. Peter Middleton has received grants from the National Health and Medical Research Centre (Ideas Grant #2036793), HCF Australia, Canadian Institutes of Health and speaker fees from AstraZeneca, Boehringer Ingelheim, the Limbic, MedEd and vertex unrelated to this study. Eve Denton declares speaker fees from Sanofi, GSK and Boehringer Ingelheim, travel grants from Menerini, Boehringer Ingelheim and Sanofi, research funding from AstraZeneca in conjunction with Optimum Patient Care Global Ltd and grants to her institution from AstraZeneca GlaxoSmithKline, Novartis, Sanofi, Teva, and Seqirus, for unrelated projects. Adrian Barnett has received speaker fees from GSK, Sanofi, Boehringer Ingelheim and travel grants from AstraZeneca and GSK. Philip Hansbro was supported by a fellowship and grants from the NHMRC (1175134, 2010287, 2008937) and by University of Technology, Sydney. Hayley Scott and Paul Griffiths declare they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"377"}}